Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve Choy

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|March 20, 2025
Less Is More: Design Considerations for Interactive Pharmacometrics Tools-A Case Study Using the Model Visualization Platform (MVP) AppSteve Choy, Jin Gyu Kim, Julia Korell
The AAPS Journal|June 2, 2016
Modeling the Disease Progression from Healthy to Overt Diabetes in ZDSD RatsSteve Choy, Willem de Winter, Mats O Karlsson, et al.
British Journal of Clinical Pharmacology|August 8, 2024
Nedosiran population pharmacokinetic and pharmacodynamic modelling and simulation to guide clinical development and dose selection in patients with primary hyperoxaluria type 1Steven Zhang, Aniruddha Amrite, Beesan Tan, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 27, 2012
Identification of the primary mechanism of action of an insulin secretagogue from meal test data in healthy volunteers based on an integrated glucose-insulin modelSteve Choy, Emilie Hénin, Jan-Stefan van der Walt, et al.
British Journal of Clinical Pharmacology|September 29, 2016
The variability in beta-cell function in placebo-treated subjects with type 2 diabetes: application of the weight-HbA1c-insulin-glucose (WHIG) modelJanna K Duong, Willem de Winter, Steve Choy, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
CPT: Pharmacometrics & Systems Pharmacology|March 20, 2025
Less Is More: Design Considerations for Interactive Pharmacometrics Tools-A Case Study Using the Model Visualization Platform (MVP) AppSteve Choy, Jin Gyu Kim, Julia Korell
The AAPS Journal|June 2, 2016
Modeling the Disease Progression from Healthy to Overt Diabetes in ZDSD RatsSteve Choy, Willem de Winter, Mats O Karlsson, et al.
British Journal of Clinical Pharmacology|August 8, 2024
Nedosiran population pharmacokinetic and pharmacodynamic modelling and simulation to guide clinical development and dose selection in patients with primary hyperoxaluria type 1Steven Zhang, Aniruddha Amrite, Beesan Tan, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 27, 2012
Identification of the primary mechanism of action of an insulin secretagogue from meal test data in healthy volunteers based on an integrated glucose-insulin modelSteve Choy, Emilie Hénin, Jan-Stefan van der Walt, et al.
British Journal of Clinical Pharmacology|September 29, 2016
The variability in beta-cell function in placebo-treated subjects with type 2 diabetes: application of the weight-HbA1c-insulin-glucose (WHIG) modelJanna K Duong, Willem de Winter, Steve Choy, et al.
Pageof 1